Veracyte, Inc. announced today the publication of an independent study showing that the Envisia Genomic Classifier enables physicians to more confidently diagnose idiopathic pulmonary fibrosis (IPF)...
Read More »Single cell RNA-sequencing in idiopathic pulmonary fibrosis
Taylor Adams presents Single Cell RNA-Sequencing of Thousands of Cells from IPF Lungs Reveals Cellular Diversity of Distinct Cellular Populations during the Environmental Influences session of the...
Read More »Researchers use single-cell RNA-Seq to unlock genetic code of diseased lung cells
A new study has determined the genetic codes of healthy and diseased human lung cells, a finding that may allow doctors to better diagnose and follow idiopathic pulmonary fibrosis (IPF) progression, as well as advance treatments for the disease. Published in the Journal ...
Read More »New Data Demonstrates Veracyte’s RNA-Seq Test Improves Idiopathic Pulmonary Fibrosis Diagnosis
Veracyte, Inc., a molecular diagnostics company pioneering the field of molecular cytology, announced findings from a new study demonstrating the potential for the company’s in-development Envisia classifier to help distinguish idiopathic pulmonary fibrosis (IPF) from other interstitial lung diseases (ILD) ...
Read More »RNA-Seq reveals genetic link between two chronic lung diseases
from Yale News by Ziba Kashef – Research on chronic lung diseases has primarily focused on studying conditions, such as emphysema or lung fibrosis, in isolation. In a new study, Yale scientists identified a common genetic network for two chronic ...
Read More »